Clinics (Sao Paulo). 2020;75:e1843.
Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis
Graziele Aparecida Simões Lima
, Rossana Verónica Mendoza López
, Gislaine Aparecida Ozório
, Ricardo Miguel Costa de Freitas
, Jose Willegaignon
, Marcelo Tatit Sapienza
, Maria Christina Chammas
, George Barberio Coura-Filho
DOI: 10.6061/clinics/2020/e1843
To systematically review and analyze the medical literature to assess ultrasonography echotexture changes in thyroid cancer patients for the detection of chronic sialadenitis caused by radioiodine therapy. Methods: Sources were retrieved from PubMed, Scopus, EMBASE and LILACS through November 2018. All studies that assessed ultrasonographic features before 131I administration and at 12 months after 131I administration were selected. After data extraction, statistical analysis was performed by using Stata software. Results: From a total of 435 studies, 4 studies involving 665 patients were considered eligible, and echotexture heterogeneity was found with a significant difference. Conclusions: Ultrasound echotexture may detect chronic sialadenitis secondary to salivary radioiodine therapy.
18
